Immunology Investor Event

Dupixent: Chronic Spontaneous Urticaria Number of patients (thousands) Prevalence (1) Biologic eligible 308 110 418 Source: Sanofi analysis (1) 12+ population 14 Immunology Investor Event 1,500 551 2,051 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 2,000 2,200 US Japan Patients uncontrolled on anti-histamines and other SoC (excluding biologics) sanofi

View entire presentation